Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
Silence Therapeutics, a biotechnology company focused on silencing diseases through precision engineered medicines, has announced its participation in four upcoming investor conferences in September 2024. The company will present overviews at the:
1. Morgan Stanley Global Healthcare Conference on September 5 at 5:35pm ET
2. HC Wainwright Global Investment Conference on September 10 at 11:30am ET
3. Cantor Global Healthcare Conference on September 17 at 10:20am ET
4. Chardan Genetic Medicines Conference on September 30 at 9:00am ET
Live audio webcasts of all presentations will be available on Silence Therapeutics' website, with replays accessible within 48 hours after each event.
Silence Therapeutics, un'azienda biotecnologica specializzata nel ridurre le malattie attraverso medicinali progettati con precisione, ha annunciato la sua partecipazione a quattro prossime conferenze per investitori a settembre 2024. L'azienda presenterà panoramiche ai seguenti eventi:
1. Conferenza globale sulla salute di Morgan Stanley il 5 settembre alle 17:35 ET
2. Conferenza globale sugli investimenti di HC Wainwright il 10 settembre alle 11:30 ET
3. Conferenza globale sulla salute di Cantor il 17 settembre alle 10:20 ET
4. Conferenza sui medicinali genetici di Chardan il 30 settembre alle 09:00 ET
I webcast audio in diretta di tutte le presentazioni saranno disponibili sul sito web di Silence Therapeutics, con le registrazioni accessibili entro 48 ore dopo ciascun evento.
Silence Therapeutics, una empresa biotecnológica enfocada en silenciar enfermedades a través de medicamentos diseñados con precisión, ha anunciado su participación en cuatro próximas conferencias para inversores en septiembre de 2024. La empresa realizará presentaciones en los siguientes eventos:
1. Conferencia Global de Salud de Morgan Stanley el 5 de septiembre a las 5:35 p.m. ET
2. Conferencia Global de Inversiones de HC Wainwright el 10 de septiembre a las 11:30 a.m. ET
3. Conferencia Global de Salud de Cantor el 17 de septiembre a las 10:20 a.m. ET
4. Conferencia de Medicinas Genéticas de Chardan el 30 de septiembre a las 9:00 a.m. ET
Las transmisiones web de audio en vivo de todas las presentaciones estarán disponibles en el sitio web de Silence Therapeutics, con repeticiones accesibles dentro de 48 horas después de cada evento.
Silence Therapeutics는 정밀하게 설계된 의약품을 통해 질병을 진정시키는 것에 초점을 맞춘 생명공학 회사로, 2024년 9월에 있을 네 개의 투자자 컨퍼런스에 참여할 것이라고 발표했습니다. 회사는 다음 이벤트에서 개요를 발표할 예정입니다:
1. 모건 스탠리 글로벌 헬스케어 컨퍼런스 9월 5일 오후 5시 35분 ET
2. HC 웨인라이트 글로벌 투자 컨퍼런스 9월 10일 오전 11시 30분 ET
3. 칸토 글로벌 헬스케어 컨퍼런스 9월 17일 오전 10시 20분 ET
4. 차르단 유전자 의약품 컨퍼런스 9월 30일 오전 9시 00분 ET
모든 발표의 실시간 오디오 웹캐스트는 Silence Therapeutics의 웹사이트에서 제공되며, 각 이벤트 후 48시간 이내에 재생할 수 있습니다.
Silence Therapeutics, une entreprise de biotechnologie axée sur le silence des maladies grâce à des médicaments conçus avec précision, a annoncé sa participation à quatre prochaines conférences d'investisseurs en septembre 2024. L'entreprise présentera des aperçus lors des événements suivants :
1. Conférence mondiale sur la santé de Morgan Stanley le 5 septembre à 17h35 ET
2. Conférence mondiale sur les investissements de HC Wainwright le 10 septembre à 11h30 ET
3. Conférence mondiale sur la santé de Cantor le 17 septembre à 10h20 ET
4. Conférence sur les médicaments génétiques de Chardan le 30 septembre à 9h00 ET
Des webcasts audio en direct de toutes les présentations seront disponibles sur le site web de Silence Therapeutics, avec des rediffusions accessibles dans les 48 heures suivant chaque événement.
Silence Therapeutics, ein biotechnologisches Unternehmen, das sich auf das Stilllegen von Krankheiten durch präzise entwickelte Medikamente spezialisiert hat, hat seine Teilnahme an vier bevorstehenden Investorenkonferenzen im September 2024 bekannt gegeben. Das Unternehmen wird Überblicke bei folgenden Veranstaltungen präsentieren:
1. Morgan Stanley Global Healthcare Conference am 5. September um 17:35 Uhr ET
2. HC Wainwright Global Investment Conference am 10. September um 11:30 Uhr ET
3. Cantor Global Healthcare Conference am 17. September um 10:20 Uhr ET
4. Chardan Genetic Medicines Conference am 30. September um 9:00 Uhr ET
Live-Audio-Webcasts aller Präsentationen werden auf der Website von Silence Therapeutics verfügbar sein, mit Wiederholungen, die innerhalb von 48 Stunden nach jeder Veranstaltung zugänglich sind.
- None.
- None.
- Morgan Stanley Global Healthcare Conference on Thursday, September 5, 2024 at 5:35pm ET
- HC Wainwright Global Investment Conference on Tuesday, September 10, 2024 at 11:30am ET
- Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 10:20am ET
- Chardan Genetic Medicines Conference on Monday, September 30, 2024 at 9:00am ET
A live audio webcast of each presentation will be available on the Company’s website at www.silence-therapeutics.com. A replay will be available on the Silence website within 48 hours after of each event.
About Silence Therapeutics
Silence Therapeutics is developing a new generation of medicines by harnessing the body's natural mechanism of RNA interference, or RNAi, to inhibit the expression of specific target genes thought to play a role in the pathology of diseases with significant unmet need. Silence's proprietary mRNAi GOLD™ platform can be used to create siRNAs (short interfering RNAs) that precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence's wholly owned product candidates include zerlasiran designed to address the high and prevalent unmet medical need in reducing cardiovascular risk in people born with elevated levels of lipoprotein(a) and divesiran designed to address hematological diseases, including polycythemia vera. Silence also maintains ongoing research and development collaborations with AstraZeneca and Hansoh Pharma, among others. For more information, please visit https://www.silence-therapeutics.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240827212540/en/
Silence Therapeutics plc
Gem Hopkins, VP, Head of IR and Corporate Communications
ir@silence-therapeutics.com
Tel: +1 (646) 637-3208
Source: Silence Therapeutics plc
FAQ
When is Silence Therapeutics (SLN) presenting at the Morgan Stanley Global Healthcare Conference in 2024?
How many investor conferences is Silence Therapeutics (SLN) participating in during September 2024?
Where can I watch the webcasts of Silence Therapeutics' (SLN) presentations at the September 2024 investor conferences?
What is the focus of Silence Therapeutics' (SLN) research and development?
